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Abstract
Background: Although cryptococcal meningitis (CM) is an emerging disease worldwide, there have been few
studies of the characteristics and risk factors of CM in children.
Methods: We used data collected from May 2007 through April 2012 in the Acute Meningitis-Encephalitis
Syndrome Surveillance project in Shi Jiazhuang, China to describe the epidemiologic, clinical, and laboratory
findings in children with CM. Furthermore, a matched case–control study was used to determine risk factors of CM.
Results: Overall 23 HIV-negative children with CM (median age: 10.91 years; range: 5 months-17 years) were enrolled
in our study. The average annual incidence of CM was 0.43/100,000 with a fatality rate of 1.7%. Most patients were
males (60.87%) and rural children (73.91%). Common clinical symptoms included increased intracranial pressure, such
as headaches (78.3%), nausea (60.9%), altered mental status (56.5%), vomiting (52.2%), and seizures (43.5%), and
frequent laboratory findings consisted of blood leukocytosis (87.0%), decreased CSF glucose (87.0%), pleocytosis
(82.6%), increased intracranial pressure (73.9%) and elevated CSF proteins (65.2%). Epidemiologic, clinical, and laboratory
findings were similar between patients with and without underlying diseases. Multivariate logistic regression analysis
showed that children who had contact with birds/bird droppings or saprophytes were more likely to be infected than
those without such contact (odds ratio(OR) =11.82; 95% confidence interval (CI), 2.21-62.24; P = 0.004). Patients with an
interval of ≥20 days from onset to admission were at high risk for CM (OR= 5.31; 95%CI, 1.58-17.89; P = 0.007).
Conclusions: Our findings show that CM is an uncommon disease with a high mortality rate in children. Although
additional studies are needed to find effective prevention and treatments for CM, clinicians should consider CM as a
potential cause for pediatric meningitis in children, particularly boys from rural areas, who had contact with birds/bird
droppings or saprophytes and in children who did not receive prompt medical attention.
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Background
Cryptococcosis is an emerging disease arising due to the
global HIV/AIDS pandemic. Cryptococcus neoformans is
the most common cause of cryptococcosis worldwide.
Cryptococcosis is responsible for cryptococcal meningitis
(CM), the most common fungal infection of the central
nervous system and a significant cause of morbidity and
mortality among patients with HIV/AIDS [1]. Few studies
of pediatric CM have been reported, but CM is believed to
be less frequent in children than in adults, regardless of
immune status [2]. Recently, higher numbers of CM cases
in children have been reported worldwide [3-13].
However, these reports come from small case studies, lit-
erature reviews, or studies comprised mostly of adults. In
addition, the epidemiologic characteristics, clinical fea-
tures, laboratory findings, and outcomes for pediatric
patients are inconsistent among the different studies. Data
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on the overall incidence of children with CM are scarce,
and understanding which children are at highest risk of
CM is lacking.
Here, we analyzed the epidemiologic characteristics,
clinical features, laboratory findings, outcomes, and risk
factors for CM in pediatric patients without HIV/AIDS.
Study subjects were identified by the Acute Meningitis
and Encephalitis Syndrome (AMES) surveillance project
in Shi Jiazhuang, China.
Methods
Data source and study population
Data for this study were obtained from the Acute
Meningitis and Encephalitis Syndrome (AMES) surveillance
database. This database contains demographic information,
clinical data, laboratory findings, and outcome for AMES
patients; trained individuals entered these data into
EPIDATA databases (http://www.epidata.dk/history.htm)
with the function of Double Entry and Validation.
Surveillance was conducted for the AMES project in
44 referral hospitals with an aggregate population of
around 5.2 million from May 2007 through April 2012,
in Shi Jiazhuang. The population in Shijiazhuang was
stable during the study period. Children < 18 years old
comprise 20.8% of the total population. Patients with
AMES traditionally seek medical care at the referral
hospitals rather than at community hospitals and private
clinics. Member hospitals receive most of the patients
across Shi Jiazhuang. An AMES case was defined as a
patient with acute onset of fever ≥38°C, changes in
mental status, and/or meningeal signs. Additionally, an
initial diagnosis in member hospitals with Japanese
encephalitis, viral encephalitis, viral meningitis, viral
meningoencephalitis, other encephalitis, meningococcal
meningitis, purulent meningitis, cerebrospinal men-
ingitis, tuberculosis meningitis, tuberculosis menin-
goencephalitis, and other meningitis also qualified as
an AMES case. AMES cases were reported to Shi
Jiazhuang CDC by clinicians in hospitals. Trained CDC
staff performed interviews. To ensure all AMES cases
were found, audits were performed every 10 days in each
hospital.
Clinicians collected blood (≥ 3 mL) and/or cerebro-
spinal fluid (CSF) samples from AMES cases with writ-
ten informed consent have been obtained from their
parents in the case of children younger than 18 years.
Routine blood test, CSF test, or culture was conducted
at each hospital laboratory. Periodic laboratory audits
were performed to ensure case ascertainment in each
laboratory. Confirmed AMES case was defined as any
AMES patient with a positive pathogen identified by
culture from CSF and/or blood. A CM case was defined
as an AMES patient with positive cryptococcal culture
from CSF and/or blood. Cryptococcal cultures were
identified by L-canavanine glycine bromothymol blue
agar. C. neoformans fails to cause a color change on the
agar, while the color of the agar changes to blue from
green in the presence of C. gattii.
Estimates of risk factors
A matched retrospective case–control study was con-
ducted in a cohort of patients with confirmed AMES to
identify risk factors for CM. The case was defined as any
patient with CM. The control was defined as any con-
firmed AMES patient due to another pathogen. All cases
and controls were obtained from the AMES database.
Each case was matched to four controls, with onset of
meningitis occurring within three months of each other.
The following data were used to examine the risk
factors: gender, age, geographic location, exposure to
birds/bird droppings or saprophytes 3 months before
illness onset, underlying disease, date of onset of illness,
and date of admission.
Data analysis
Continuous variables were summarized as medians with
ranges. Categorical variables were summarized as
proportions. Fisher's exact test was used to compare the
categorical variable between patients without underlying
diseases and those with underlying diseases. Univariate
conditional logistic regression models were used to
examine gender, age, geographic location, underlying
diseases, contact history of birds/bird droppings or
saprophytes, and the time interval from illness onset to
hospital admission. All variables with a P value <0.10
upon univariate analysis were included in a multivariate
conditional logistic regression model to evaluate their
independent effects. Backward logistic regression was
conducted by removing variables with P > 0.10 upon
multivariate conditional logistic regression. Statistical
significance was defined as P < 0.05. Data were analyzed
using the Stata version 9.0 statistical software (StataPress,
College Station, TX, USA).
Ethical considerations
The Ethics Committee of Shi Jiazhuang CDC and ethical




Over a 5-year study period, 23 cases of pediatric CM
(Median age: 10.91 years; Range: 5 months-17 years) due
to C. neoformans were confirmed from positive CSF
cultures of HIV-negative children. The average annual
incidence and fatality rate of CM was found to be 0.43/
100,000 and 1.74% among children < 18 years old. Most
of the patients identified were males (60.87%) and from
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rural environments (73.91%). About half of the patients
(43.48%) emerged in June-August during the 5-year
period. Most cases (78.26%) had contact with birds/bird
droppings or saprophytes before illness onset and 26.1%
of the cases had underlying diseases (1 patients with
hepatitis B, 1 with renal disease, 1 with diabetes, 1 with
aplastic anemia, 1 with tuberculosis, and 1 with hand-foot-
mouth disease). None of the patients had traveled outside
his/her district for at least one year before becoming ill.
Epidemiologic characteristics of patients with or without
underlying diseases did not differ (Table 1).
Clinical features and laboratory findings
The median duration from illness onset to hospital
admission was 33 days (range: 2–48 days). The initial
diagnoses included meningitis (34.78%), bacterial menin-
gitis (30.43%), viral meningitis (21.74%), and tuberculosis
meningitis (13.04%). The first symptoms were actue
fever in 78.3% of the patients and headache in 65.2%.
Frequent symptoms and signs were fever (100%), head-
ache (78.3%), nausea (60.9%), altered mental status
(56.5%), vomiting (52.2%), seizures (43.5%), meningeal
signs (34.8%), and stiff neck (30.4%) (Table 1). Blood
leukocytosis (87.0%), decreased CSF glucose (87.0%),
pleocytosis (82.6%), increased intracranial pressure
(73.9%) and elevated CSF proteins (65.2%) were found in
most patients (Table 1). Clinical features and laboratory
findings did not differ significantly between patients with
or without underlying diseases (Table 1).
Outcome
The median length of hospitalization was 22 days
(range: 13–34 days). One patient without underlying
disease and another with renal disease died during
hospitalization. At discharge, 18 cases had recovered
and 3 cases had complications, one with hearing dam-
age, one with mild papilloedema, and one with blurred
vision. These 3 patients had recovered by the 6-month
follow-up.
Risk factors
Univariate conditional logistic analysis was used to iden-
tify risk factors associated with CM patients in compari-
son to patients with other types of meningitis (Table 2).
When compared to patients < 5 years old, patients ≥ 10
and <15 years old (odds ratio (OR) = 4.36; 95% confidence
interval (CI), 1.12-9.81; P = 0.033) or patients ≥ 15
and <18 years old (OR = 5.53; 95%CI, 1.19-25.79; P =
0.029) were significantly associated with CM. Contact with
birds/bird droppings or saprophytes was associated with
CM (OR = 9.32; 95%CI, 2.54-34.23; P = 0.001). An interval
of ≥10 days and <20 days from illness onset to hospital
admission (OR = 2.22; 95%CI, 0.35-14.15; P = 0.398) was
not significantly associated with CM, whereas an interval
of ≥20 days from onset to admission was significantly asso-
ciated with CM (OR = 11.39; 95%CI, 2.20-59.02; P = 0.004).
Furthermore, we performed a multivariate conditional
logistic regression analysis of risk factors for CM
(Table 3). Subjects with a history of contact with birds/
bird droppings or saprophytes were more likely to be
infected than those without contact (OR = 11.82; 95%CI,
2.21-62.24; P = 0.004).
Overall, our findings suggest that contact with birds/
bird droppings or saprophytes and a longer interval from
illness onset to hospital admission are independent risk
factors for CM.
Discussion
Here, we analyzed epidemiology, clinical and laboratory
characteristics, and risk factors associated with CM due
to C. neoformans in HIV-negative children. Similar to
the incidence in children of Taiwan with unknown HIV
status reported previously [11], we found an average
annual incidence of 4.3 cases of CM per million HIV-
negative children with a fatality rate of 1.7% in main-
land China.
Two species in the genus Cryptococcus, C. neoformans
and C. gattii, can infect humans. The former, which is
found commonly worldwide, infects mostly immuno-
compromised patients [14,15], whereas the latter affects
both immunocompetent and immunocompromised indi-
viduals [16,17]. In our study, children without under-
lying diseases comprised 74% of CM patients caused by
C. neoformans, consistent with other reports from main-
land China [18]. This finding may be explained by the
genetic homogeneity between Chinese C. neoformans
strains [18]. However, data demonstrate that C. gattii,
which was formerly described as a geographically
restricted species [19], is spreading at a great rate around
the globe. Cases caused by this species have been
reported not only from the tropical and subtropical
areas, but also from the Pacific coast of Canada and the
United States [20]. Moreover, China, Europe, and Japan
confirm that this fungus can also occur in temperate
climates [18,21,22].
The proportion of immunocompetent patients with
CM varies greatly between the HIV-negative patients in
different regions and countries [8,23-28], regardless of
the age of patients. For example, in Taiwan, about 50%
of HIV-negative children with CM exhibited underlying
disease [8,23] whereas 38% of CM patients in India had
no underlying disease [24]; in Vietnam, 81% of the CM
patients had no underlying disease [25], but in the
United States, about 70% of HIV-negative adults with
CM had underlying disease [26]. Subtle defects in im-
munity [27] or idiopathic CD4 lymphopenia [28] could
account for these variations, as could ethnic differences.
Further studies are needed to determine the cause of
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Table 1 Characteristics of pediatric patients with cryptococcal meningitis
Characteristic Patients without underlying
diseases (%) (n = 17)
Patients with underlying





Male 11 (78.6) 3 (50.0) 14 (78.6) 0.643
Age, years 0.835
0-5 3 (17.6) 1 (16.7) 4 (17.4)
5-10 5 (29.4) 1 (16.7) 6 (26.1)
10-15 7 (41.2) 2 (33.3) 9 (39.1)
15-17 2 (11.8) 2 (33.3) 4 (17.4)
Geographic location
Rural area 13 (76.5) 4 (66.7) 17 (73.9) 0.632
Date of illness onset 0.444
December-February 5(29.4) 0(0.0) 5 (21.7)
March-May 3(17.6) 1(16.7) 4 (17.4)
June-August 7(41.2) 3(50.0) 10 (43.5)
September-November 2(11.8) 2(33.3) 4 (17.4)
Contact with birds/droppings or saprophytes† 12 (70.6) 6 (100.0) 18 (78.3) 0.274
Time from illness onset to hospitalization (days) 0.093
1-10 2 (11.8) 1 (16.7) 3(13.0)
10-20 2 (11.8) 1 (16.7) 3 (13.0)
20-30 11 (78.6) 1 (16.7) 12 (52.2)
≥30 2 (11.8) 3 (66.7) 5 (21.7)
Clinical symptoms and signs
Fever (≥39°C) 8 (47.1) 5 (83.3) 13 (56.5) 0.179
Headache 13 (76.5) 5 (83.3) 18 (78.3) 1.000
Nausea 9 (52.9) 5 (83.3) 14 (78.6) 0.340
Altered mental status 10 (58.8) 3 (50.0) 13 (56.5) 1.000
Vomiting 10 (58.8) 2 (33.3) 12 (52.2) 0.371
Seizures 6 (35.3) 4 (66.7) 10 (43.5) 0.341
Meningeal signs 5 (29.4) 3 (50.0) 8 (34.8) 0.621
Neck stiffness 6 (35.3) 1 (16.7) 7 (30.4) 0.621
Hearing damage 3 (17.6) 1 (16.7) 4 (17.4) 1.000
Visual damage 3 (17.6) 0 (0.0) 3 (13.0) 0.539
Bregmatic eminence 1 (5.9) 0 (0.0) 1 (4.3) 1.000
Laboratory findings
Blood leukocytosis (≥15 × 109/L) 15 (65.2) 5 (83.3) 20 (87.0) 1.000
Decreased CSF glucose (<3.1 mmol/L) 16 (94.1) 4 (66.7) 20 (87.0) 0.155
Pleocytosis (×106/L) 0.483
<10 4 (23.5) 0 (0.0) 4 (17.4)
10-100 7 (41.2) 2 (33.3) 9 (39.1)
≥100 6 (35.3) 4 (66.7) 10 (43.5)
Elevated CSF proteins (≥0.45 g/L) 10 (58.8) 5 (83.3) 15 (65.2) 0.369
Intracranial pressure(>250 mm H2O) 14(82.4) 3(50.0) 17 (73.9) 0.279
*Underlying diseases included hepatitis B (1 case, 3 controls), renal disease (1 case, 2 controls), diabetes (1 case, 1 control), aplastic anemia (1 cases, 1 controls),
tuberculosis and hepatitis B (1 case, 1 control), and hand-foot-mouth disease (1 case, 4 controls).
†Birds included pigeons, chicken, or parrots; saprophytes included soils, grassland, or rotten vegetables and fruits.
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regional variation in the incidence of CM among
immunocompetent populations.
However, the epidemiologic characteristics, clinical
features, and laboratory findings associated with CM
were similar for children with and without underlying
diseases. The median age of infected children was about
12 years old, consistent with prior studies of CM in
HIV-negative children [8,9]. Like in other hospital-based
reports of CM in children, most of the patients in our
study were boys [12,29]. A population-based surveillance
in South Africa also showed that boys are significantly
more likely to become infected with cryptococcosis than
adults, but it did not evaluate the gender distribution for
CM in children [30].
Of the children included in our study, 73.9% of the
patients were from rural areas, suggesting that there is
increased environmental exposure in rural areas. Similar
results were obtained in a population-based study in
Australia and New Zealand [4], although few HIV-
negative children with CM were included in these stud-
ies. Furthermore, about half of the CM cases in our
study occurred in summer in Shijiazhuang; the reason
for this is unclear. Although time distribution is an
important epidemiologic characteristic of diseases, the
seasonal distribution of CM in children has not been
reported. When compared to children with meningitis
caused by other pathogens, a conditional logistic analysis
showed that age, gender, and geographic location were
not risk factors for CM in pediatric patients. We did not
test onset of illness as a risk factor, because it was the
matching variable in the case–control study. Thus, fur-
ther studies are needed to confirm whether or not age,
gender, geographic location, and onset of illness are risk
factors associated with CM in children.
In our study, fever was the most frequent sign of CM,
followed by headache, nausea, altered mental status, and
vomiting. Hearing and visual damage were less common
during the course of the disease. These frequent charac-
teristics were secondary to increased intracranial pres-
sure (ICP) and consistent with the laboratory findings of
ICP. Pleocytosis, elevated CSF proteins, and decreased
CSF glucose levels were also common. These clinical
and laboratory findings are somewhat different from
those previously reported in HIV-negative or HIV-
positive children [8,12,29]. In HIV-negative children
with CM, one study reported a meningeal irritation sign
to be the most common manifestation, followed by
headache, vomiting, and pleocytosis in 9 HIV-negative
children with CM [8]. Yet another study described hear-
ing and visual damage to be common symptoms in 11
HIV-negative children with CM [12]. These different
clinical and laboratory findings may be due to different
patient populations enrolled in the various studies. The
main reason for the difference between HIV-negative or
HIV-positive children may be the immune status of the
Table 3 Multivariate conditional logistic analysis of risk
factors for cryptococcal meningitis among patients with
meningitis and encephalitis
Risk Factor P value OR (95%CI)
Time from illness onset to hospital
admission (≥20 day)
0.007 5.31(1.58-17.89)
Contact with birds/droppings or
saprophytes*
0.004 11.82(2.21-62.24)
* Birds included pigeons, chicken, or parrots; saprophytes included soils,
grassland, or rotten vegetables and fruits.
Table 2 Univariate conditional logistic analysis of risk








P value OR (95%CI)
Gender
Female 9 (21.4) 51 (55.4) Reference
Male 14 (78.6) 41 (44.6) 0.190 1.81 (0.75-4.38)
Age, years
0-5 4 (17.4) 36 (39.1) Reference
5-10 6 (26.1) 29 (31.5) 0.612 1.51 (0.31-7.35)
10-15 9 (39.1) 21 (22.8) 0.033 4.36 (1.12-9.81)
15-17 4 (17.4) 6 (6.5) 0.029 5.53 (1.19-25.79)
Geographic location
Urban areas 6 (26.1) 32 (34.8) Reference





1-10 2 (8.7) 35 (38.0) Reference
10-20 3 (13.0) 24 (26.1) 0.398 2.22 (0.35-14.15)
20-30 12 (52.2) 17 (18.5) 0.004 11.39 (2.20-59.02)




No 5 (21.7) 56 (60.9) Reference
Yes 18 (78.3) 36 (39.1) 0.001 9.32 (2.54-34.23)
Underlying
disease†
No 17 (73.9) 80 (87.0) Reference
Yes 6 (26.1) 12 (13.0) 0.160 2.05 (0.75-5.58)
* Birds included pigeons, chicken, or parrots; saprophytes included soils,
grassland, or rotten vegetables and fruits.
† Underlying diseases included hepatitis B (1 case, 3 controls), renal disease
(1 case, 2 controls), diabetes (1 case, 1 control), aplastic anemia (1 case, 1
control), tuberculosis and hepatitis B(1 case, 1 control), and hand-foot-mouth
disease (1 case, 4 controls).
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patients. Overall, the characteristics of CM did not differ
from those of other forms of meningitis, thus we could
confirm the diagnosis of CM only through identification
of Cryptococcus in the CSF. The difficulty in diagnosis is
likely why patients were misdiagnosed with other forms
of meningitis prior to CSF culture.
Although the characteristics of CM are indistinguish-
able from other forms of meningitis, the treatment may
differ. Thus, early identification and prevention are crit-
ical for management of CM in the pediatric population.
Infection with HIV/AIDS is the most common risk
factor for CM in adults, followed by other comorbid
conditions, such as cancer, organ transplantation, renal
disease, and connective tissue disorders. Furthermore, a
population-based multistate study revealed smoking and
outdoor occupations are associated with an increased
risk of cryptococcosis in adults infected with HIV [3].
However, the risk factors associated with CM in children
have not been defined. Our study shows that contact
with birds/bird droppings or saprophytes and a longer
interval between onset of illness and hospital admission
are independent risk factors for CM, but not for other
types of meningitis in children. In contrast to children
with meningitis due to other pathogens, underlying
disease in children with CM is not a significant risk
factor. Thus, our findings suggest that contact with
birds/bird droppings or saprophytes and a longer interval
between onset of illness and hospital admission may be
used to distinguish CM from other types of meningitis in
pediatric patients.
Although our observations provide valuable insight
into pediatric CM, they are not without limitations. The
incidence of HIV-negative children with CM was likely
underestimated because only fungal culture was used to
identify C. neoformans. The traditional diagnostic tech-
niques used to identify this infection include culture
analysis, India ink staining of CSF, and cryptococcal
polysaccharide antigen detection in the serum and CSF.
Lateral flow immunoassay is a new diagnostic method
for cryptococcosis, and it shows comparable results to
the widely approved enzyme immunoassay for crypto-
coccal antigen [31]. Although every one of these meth-
ods can be used to detect cryptococcosis, a combination
of methods may detect more cases with incidences
closer to those reported for HIV-negative children with
CM in Shi Jiazhuang. Additionally, the sample size used
in this study may have limited the power to detect risk
factors although our results are statistically significant
and support our conclusion that exposure to birds/bird
droppings or saprophytes and the interval from illness
onset to hospital admission are independent risk factors
for CM. However, a larger sample size may allow detec-
tion of additional risk factors. Continuous surveillance
or a multicenter study would need to be conducted to
detect more cases that could be used to assess for
additional risk factors. Furthermore, although half of the
CM cases emerged in summer, this case–control study
lacks a matched variable that would have allowed us to
determine if there is a seasonal risk of developing
pediatric CM.
Overall, our findings suggest that we should reconsider
strategies for managing and preventing CM in children.
Instead of simply administering drug prophylaxis, a pri-
mary, secondary, and tertiary strategy for prevention and
control of CM could be tailored to individuals at high
risk for CM. For instance, our results suggest that chil-
dren should avoid contact with birds/bird droppings and
saprophytes, sick children should receive medical care as
soon as possible, and clinicians need to consider CM as
a potential cause for meningitis especially in boys and in
children, who had contact with birds/bird droppings or
saprophytes and in children who did not receive prompt
medical attention. Furthermore, public health studies are
needed to identify and/or develop effective antifungal
drugs, vaccines [32], and screening strategies [33].
Conclusions
In summary, we found that although CM is not common
in HIV-negative children, the mortality rate associated
with CM is high in HIV-negative children. The epidemi-
ology and clinical and laboratory characteristics of CM
do not differ between HIV-negative children with under-
lying diseases and those without underlying diseases.
Boys and children from rural areas represented most
cases of pediatric CM. Children exposed to birds/bird
droppings or saprophytes and children who did not
receive prompt medical attention were at high risk for
CM, whereas these factors were not associated with risk
for other types of meningitis. These findings suggest that
avoidance of environmental risk factors and prompt
medical attention are important for the prevention and
management of CM among children. Clinicians should
consider CM as a potential cause for pediatric meningitis
in children with factors mentioned above. Further studies
are needed to identify the most effective measures to
confront CM.
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